Austco Healthcare Limited (ASX: AHC)
Health Care · Health Care Equipment & Supplies · AU
AU$0.24
-6.00% today · -42.7% 1Y
Austco Healthcare Limited (ASX: AHC) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $61.46M and employs 102 people.
Over the last twelve months the share price has lost 42.7%, trading between 0.19 and 0.45.
Tweenvest scores Austco Healthcare Limited across four factors: quality 71/100, value 73/100, growth 76/100. Its strongest factor is growth.
AHC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $61.46M
- Revenue (TTM)
- $65.20M
- P/E
- 9.86
- EPS
- 0.02
- Dividend yield
- —
- Beta (5Y)
- 0.32
- 52-week high
- AU$0.45
- 52-week low
- AU$0.19
- Avg volume (3M)
- —
- Shares outstanding
- 374.75M
- Employees
- 102
- Next earnings
- —
About Austco Healthcare Limited
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends across Australia, New Zealand, Asia, Europe, and North America. A significant product in its portfolio is Tacera, an internet protocol (IP) based nurse call solution specifically engineered for both hospitals and aged care facilities. Originally founded in 1986, the company adopted its current name, Austco Healthcare Limited, in November 2020, having previously been known as Azure Healthcare Limited. Its corporate headquarters are located in Port Melbourne, Australia.
- ISIN
- AU0000120818
- Founded
- 1986
- Listed since
- Sep 24, 2004
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OSTEONIC Co., Ltd.KOSDAQ: A226400 | $63.42M | ₩4,250.00 | +2.04% |
| Gentian Diagnostics ASAOB: GENT | $63.02M | Nkr38.50 | -1.28% |
| Creo Medical Group PLCAIM: CREO | $62.28M | £0.11 | 0.00% |
| Abingdon Health PlcAIM: ABDX | $61.89M | £0.11 | 0.00% |
| OK Biotech Co., Ltd.TWSE: 4155 | $61.26M | NT$14.20 | -4.38% |
| Venus Medtech (Hangzhou) Inc.SEHK: 2500 | $61.10M | HK$1.10 | -8.37% |
| Daxor CorporationNasdaqCM: DXR | $60.78M | $10.49 | +0.77% |
| Vincent Medical Holdings LimitedSEHK: 1612 | $60.56M | HK$0.72 | +6.67% |
Figures last refreshed Oct 11, 2026.